Skip to the content
pharmaceutical daily

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • News by region
    • East and Central Asia
    • Europe
    • Latin America
    • Middle East and North Africa
    • North America
  • Pharma Business
  • My Pharmaceutical
  • About us
    • Media Kit
    • Privacy Policy
  • Contact

Tag: thalassemia

Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment
December 15, 2016 Off

Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment

By Dino Mustafić

Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders…

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

March 6, 2021 0

Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

March 6, 2021 0

Sensient Publishes Its Sixth Annual Sustainability Report With Performance Highlights and SASB Disclosures

March 6, 2021 0

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement

March 5, 2021 Off
Proudly powered by WordPress | Theme: Envo Magazine